Pathologist

Medical School:
University of Chicago, Chicago, IL, 1992, PhD

Certification:
Certified Specialist in Molecular Biology, ClSpMB (NCA) Clinical Laboratory Director, CLDir (NCA)

Current Academic Appointment:
Assistant Professor of Pathology

Selected Bibliography:
Textbooks
Buckingham, LE, Flaws ML. Molecular Diagnostics: Fundamentals, Methods and Clinical Applications. 2007. F.A. Davis, Philadelphia, PA.

Selected Bibliography:

Buckingham, LE, Faber LP, Kim AW, Kaiser K, Barger C, Basu S, Liptay MJ, Bonomi P, Coon JS. Tumor suppressor gene CpG site methylation and outcome in surgically treated stage I-II non-small cell lung cancer patients. J Clin Oncol 26(15s):586s, 2008

Buckingham, LE, Faber LP, Kim A, Kaiser K, Basu S, Liptay M, Bonomi P, Coon JS. Gene Promoter Methylation and Outcome in Surgically Treated Stage I-II Non-Small Cell Lung Cancer Patients. American Association for Cancer Research, Abstract No. 08-AB-5246-AACR, 2008

Buckingham LE, Coon JS, Morrison LE, Jacobson KKB, Jewell SS, Kaiser KA, Mauer AM, Muzzafar T, Polowy C, Basu S, Gale M, Villaflor VM, Bonomi P. The prognostic value of chromosome 7 polysomy in non-small cell lung cancer patients treated with Gefitinib. Journal of Thoracic Oncology 2(5):414-422, 2007.

Fidler, MJ, Buckingham L, Gale M, Coon J, Mauer A, Villaflor V, Kaiser K, McCormack S, Morrison L, Bonomi P. Clinical and molecular characteristics of advanced non-small cell lung cancer (NSCLC) patients with rapid progressive disease on gefitinib therapy. Amer. Soc. for Clin. Oncol., Abstract No. 07-AB-31766-ASCO, 2007.

Villaflor, VM, Buckingham L, Gale M, Coon J, Mauer AM, Muzzafar T, Kaiser K, McCormack S, Morrison L, Bonomi P. EGFR mutations IHC and FISH status, and chromosome 7 gene copy number combined with pAkt expression as potential predictors of survival in non-small cell lung cancer patients treated with gefitinib. Amer. Soc. for Clin. Oncol., Abstract No. 06-AB-34107-ASCO, 2006.